The proportion of incident patients achieving normalized IGF-I values (defined as IGF-I ≤ 1.2 × ULN) at follow-up 3–5 years after acromegaly diagnosis (mean 4.2 ± 0.9 years) significantly increased over time (Figure 3A). This evidence concerns the gene IGF1 and acromegaly.